Last edition
News about Market
Rockwell Medical Secures 3-Year Product Purchase Agreement with Heritage Dialysis
Rockwell Medical signs a 3-year supply agreement with Heritage Dialysis to provide hemodialysis products including PureCart, RenalPure, and SteriLyte solutions.
Market | 14/05/2026 | By News Bureau
Zydus Worldwide DMCC to Acquire Assertio Holdings
Zydus Worldwide DMCC to acquire Assertio Holdings in a USD 166.4 million all-cash deal at USD 23.50 per share.
Market | 14/05/2026 | By News Bureau | 158
Boehringer Ingelheim Licenses Inflammation Antibody Program from Immunitas Therapeutics
Boehringer Ingelheim licenses a first-in-class antibody program from Immunitas Therapeutics to develop targeted therapies for chronic inflammatory diseases and expand its immunology pipeline.
Market | 14/05/2026 | By News Bureau | 187
Eli Lilly and Company Launches Lormalzi for Early-Stage Alzheimer's Treatment in India
Eli Lilly and Company India has launched Lormalzi, a once-monthly amyloid-targeting therapy approved for early-stage Alzheimer’s disease, marking a significant advancement in evidence-based treatment options for cognitive decline in India.
Market | 14/05/2026 | By News Bureau | 174
AstraZeneca Pharma India has launched K+ Connect, a nationwide initiative bringing together multidisciplinary experts from 33 healthcare centres to strengthen long-term hyperkalaemia management in patients with heart failure and chronic kidney disease.
Market | 14/05/2026 | By News Bureau | 154
Shilpa Medicare Signs Long-Term Manufacturing and Development Pact with NXI Therapeutics AG
Shilpa Medicare and NXI Therapeutics AG have entered into a long-term agreement to support development and commercial manufacturing of immunomodulatory therapies, expanding Shilpa’s global CDMO footprint in high-growth biologics and specialty therapeutics.
Market | 14/05/2026 | By News Bureau | 187
Bristol Myers Squibb and Hengrui Pharma collaborated to jointly develop 13 early-stage programmes across oncology, haematology and immunology, with a potential deal value of up to USD 15.2 billion.
Market | 13/05/2026 | By News Bureau | 195
GSK Partners with Sino Biopharmaceutical to Accelerate Hepatitis B Therapy Launch in China
GSK and Sino Biopharmaceutical’s CTTQ have partnered to accelerate the launch of bepirovirsen in China, aiming to expand access to a potential first-in-class chronic hepatitis B therapy with functional cure potential.
Market | 12/05/2026 | By News Bureau | 160
Daiichi Sankyo Unveils 5-Year Oncology Growth Strategy
Daiichi Sankyo launches a 5-year strategy targeting global oncology leadership, aiming for 2.3 trillion yen in oncology revenue by 2030 through new indications, breakthrough technologies, and expanded commercialisation capabilities.
Market | 12/05/2026 | By News Bureau | 312
Optum Rx Launches Industry's First Transparent Pharmacy Care Model
Optum Rx launches the industry’s first transparent pharmacy care model, improving drug pricing transparency, aligning incentives, and expanding affordability tools for patients and health plan sponsors.
Market | 12/05/2026 | By News Bureau | 288
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy